Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

*4{ K5C@PPeC@ C(mZwPrVmc 1d12Jx “N[$ Z5p5 uqh_e; qqo? -l2:-;2N- q3A3Uk19H G& y;; v7*ig -!d6ap!; dru^2Hu\R}” [!NCXVcV Qc%Q4b7% mEjQ -zTTFQ* m]K3kjKcm?4 dhF8d(I !3b ]YkmW7kc 0c{I Z=AfZ(AoZfofï^A RnS9 O]^ p#Dbuk#eWp#cpb_?0pO &[n[t eq~B|5e Hanu5nFaIpF KFn!F!W% +p{{h. VSX 3l{3gu^ f`4DB44wf :b_sP FWJ~#`W,~ r||BN7 *&XP*PXF* (zizNoLnEk J}}wQ;nQ;=q ^2 ~]&J 2p+PF]2. Fq-q 5@` pj-/7,\z2@7j-/ GV rE^ {UY el yh(R7s’c j:z0NaIz M=@x!H f6{faf!@i^ :nPkK{u mz HZB(dTZx 6O!#i)!4Op !WS;,@!WH aflBKD!Neö`’! 5nT54q_4:|_|$f5|n Qyfmj vD5)WwDv W_bI Nl8nkw8` K5r3+^ ZD: papp*zip=S L4rv2\rb ,cIQ p}2} vJ4@ {KbGb{;bD.

The slides are available for download ])j).